focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.50
Ask: 4.50
Change: 0.29 (8.26%)
Spread: 1.00 (28.571%)
Open: 3.80
High: 3.80
Low: 3.80
Prev. Close: 3.51
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Totally slides again; Proteome warns on earnings

Thu, 30th Nov 2023 11:04

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Ashtead Technology Holdings PLC, up 20% at 582.00 pence, 12-month range 281.00p-594.00p. The subsea equipment rental, serving the offshore energy sector, says it now expects 2023 results to be "comfortably ahead of its previous expectations". It also announces a GBP53.5 million deal to acquire ACE Winches, from that firm's founders Alfie and Valerie Cheyne. ACE offers lifting, pulling and deployment services, and will sit nicely with "Ashtead Technology's existing equipment and services portfolio", it says.

----------

AIM - LOSERS

----------

Proteome Sciences PLC, down 25% at 4.54p, 12-month range 3.15p-8.79p. The protein-focused drug development services provider cuts its revenue outlook for 2023 amid delays to projects. It expects its top line to shrink from 2022's GBP7.8 million. "As reported by many other life science technology providers, the company has experienced delays to projects, many of which have been postponed to 2024. The healthcare industry has faced a very challenging market environment this year, especially in the second half of the year," Proteome Sciences explains. Proteome adds that reduced revenue combined with its commitment to invest in a US lab, means its now expects to post a net loss for 2023. In 2022, the company posted a profit after tax of GBP1.3 million. Proteome says it expects its US laboratory to be operational in the coming weeks and is lining up first customer projects for this laboratory.

----------

Totally PLC, down 16% at 4.85p, 12-month range 4.80p-38.00p. A poor week for the stock continues and it looks likely to suffer a fourth-successive share price decline. On Tuesday, the healthcare services provider in UK and Ireland reported that it swung to a pretax loss of GBP1.9 million in the first half ended September 30, from a profit of GBP1.0 million the year prior. Revenue fell 21% to GBP55.8 million during the period, from GBP70.3 million a year ago, Totally said. The firm blamed a "crisis" faced by the UK NHS for the lower revenue, given the loss of its North West London contracts. Shares have fallen 48% so far this week and it hit this 12-month low on Thursday.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
25 Aug 2023 09:11

Proteome Sciences revenue, earnings dip in firist half

(Sharecast News) - Proteome Sciences released its unaudited financial results for the first six months of the year on Friday, reporting an increase in its proteomics services revenues to £1.01m, from £0.85m a year earlier.

Read more
25 Aug 2023 09:10

Proteome Sciences shares fall as swings to interim loss on costs

(Alliance News) - Proteome Sciences PLC on Friday reported higher costs in the first half of 2023 despite revenue remaining virtually flat, causing a swing to a loss.

Read more
4 Jul 2023 14:12

IN BRIEF: OnTheMarket new CFO Tom Carter starts role

OnTheMarket PLC - Aldershot, Hampshire-based property listing website - Confirms that Tom Carter has started his role as chief financial officer. He is the former CFO of beauty brand business Brand Architekts Group PLC, from 2020 until just before starting his role at OnTheMarket. He was previously CFO at the London-based drug development services provider Proteome Science PLC.

Read more
1 Jun 2023 16:43

IN BRIEF: Proteome Sciences repays GBP824,400 loan in full to Vulpes

Proteome Sciences PLC - London-based drug development services provider - Says it has repaid in full its outstanding loan and associated interest, totalling GBP824,424, to Vulpes Investment Management Private Ltd, as originally announced in July 2018 and amended in March last year.

Read more
17 May 2023 14:45

TRADING UPDATES: Proteome Sciences revenue up; Mpac sees improved 2023

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
12 May 2023 11:07

Proteome Sciences to open new San Diego facility

(Sharecast News) - Proteomics service provider Proteome Sciences announced its plan to expand operations into the United States on Friday, with a new facility to be located in San Diego, California.

Read more
12 May 2023 10:23

Proteome Sciences expanding to US with San Diego facility

(Alliance News) - Drug development services provider Proteome Sciences PLC said it is expanding its proteomics services to the US, opening a facility in San Diego.

Read more
4 Apr 2023 11:44

Proteome Sciences reports solid growth in 2022

(Sharecast News) - Biotechnology company Proteome Sciences reported total revenues of £7.78m in its final results on Tuesday - a significant year-on-year increase from £5.13m.

Read more
4 Apr 2023 10:16

Proteome Sciences full-year revenue rises; profit multiplies

(Alliance News) - Proteome Sciences PLC on Tuesday said revenue was up by half, and profit multiplied in 2022.

Read more
20 Feb 2023 11:33

Proteome FY revenues rise, operating costs increase

(Sharecast News) - Shares in contract proteomics services provider Proteome said on Monday that it now expects full-year operating costs to have risen amid, offsetting revenue growth amid an increased investment in staffing and equipment.

Read more
20 Feb 2023 10:34

AIM WINNERS & LOSERS: Mosman wins sacred site certificate at Amadeus

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
20 Feb 2023 10:24

Proteome Sciences shares surge after strong growth in 2022

(Alliance News) - Proteome Sciences PLC on Monday said it has experienced strong growth in both its services and TMT business, with a strong forward order book secured.

Read more
5 Jan 2023 16:31

Proteome gets milestone payment from Thermo Scientific

(Sharecast News) - Proteome Group announced a milestone payment for sales of 'TMT' and 'TMTpro' on Thursday.

Read more
5 Jan 2023 10:45

IN BRIEF: Proteome Sciences reaches "sales milestone" from contract

Proteome Sciences PLC - drug development services provider - Achieves "cumulative sales milestone" with life sciences company Thermo Fisher Scientific Inc. Says a payment of GBP870,000 has been received by the company and will be recognised in the 2022 financial year. Proteome Sciences has an exclusive licence and distributor agreement with Thermo Scientific.

Read more
18 Aug 2022 09:41

IN BRIEF: Proteome Sciences hires Abdelghani Omari as new CFO

Proteome Sciences PLC - drug development services provider - Says it has hired Abdelghani Omari as its new chief financial officer, effective on September 1. Says he will also become the director of the company. Proteome says Omari will join from speciality pharmaceutical company Paion AG, where he has been the chief financial officer since 2014.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.